Platelets in Chronic Liver Disease: Beyond Numbers
International Research Journal of Gastroenterology and Hepatology,
Objectives: Thrombocytopenia, a complication of Chronic Liver Disease (CLD), is considered to be a marker of advanced disease and an independent predictor of mortality. But this is disputable and hence is this study 1. To find out prevalence of thrombocytopenia in CLD; 2. To find out association with severity of liver disease and thrombocytopenia.
Materials And Methods: This was a descriptive study analyzing CLD patients diagnosed by clinical, biochemical, serological and radiological evaluation in our institution between March 2019 and December 2020.
Results: There were 48 patients; M: F 43:5; mean age 51.7±12.4 years; Thrombocytopenia: Mild (149999 – 75000/mm3) in 45.8%, moderate (74999 – 50000/mm3) in 12.5% and severe (< 49999/mm3) in 8.3%. There was no association of thrombocytopenia with severity indices like Child-Pugh Class (C. P. C.) and Model for End-stage Liver Disease – Sodium (MELD-Na) Score.
Conclusion: The prevalence of thrombocytopenia in CLD is 66.6% in this study. Thrombocytopenia is not associated with severity of disease. This necessitates larger studies and analyzing the factors other than number of platelets. This includes 1. functional status of platelets (thrombocythemia) 2. In a stable CLD, haemostasis and coagulation pathways achieve a delicate “rebalance state” (new normal) which may be disturbed even by trivial insult. 3. Platelets also secrete platelet derived growth factor, transforming growth factor β, hepatocyte growth factor which can influence liver fibrosis and regeneration.
- chronic liver disease
- portal hypertension
How to Cite
Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver International. 2016;37(6):778-793.
Nilles K, Flamm S. Thrombocytopenia in chronic liver disease. Clinics in Liver Disease. 2020;24(3):437-451.
Moore A. Thrombocytopenia in cirrhosis: A review of pathophysiology and management options. Clinical Liver Disease. 2019;14(5):183.
Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, etal. Platelet count/spleen diameter ratio: Proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. FREE.Gut. 2003;52(8):1200-1205.
Alam R, Karim AB, Rukunuzzaman M, et al. Non-endoscopic predictors of esophageal varices in children with chronic liver disease and their utility in resource-constrained countries. Indian J Gastroenterol. 2019;38;310–316.
Giannini E. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Alimentary Pharmacology and Therapeutics. 2006;23(8):1055-1065.
Afdhal N, Esteban R. Introduction: Thrombocytopenia in chronic liver disease - treatment implications and novel approaches. Alimentary Pharmacology & Therapeutics. 2007;26:1-4.
Sigal S, Mitchell O, Feldman D, Diakow M. The pathophysiology of thrombocytopenia in chronic liver disease. Hepatic Medicine: Evidence and Research. 2016;39:778-793.
Rubin MH, Weston MJ, Langley PG, White Y, Williams R. Platelet function in chronic liver disease: Relationship to disease severity. Dig Dis Sci. 1979;24(3):197-202.
DOI: 10.1007/BF01308429 PMID: 456208.
Amir A Qamar, Norman D Grace, Roberto J Groszmann, Guadalupe Garcia–Tsao, Jaime Bosch, Andrew K Burroughs, et al. Prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis, clinical gastroenterology and hepatology. 2009;7(6):689-695. ISSN 1542-3565,
Gotlieb N, Schwartz N, Zelber-Sagi S, Chodick G, Shalev V, Shibolet O. Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World Journal of Gastroenterology. 2020;26(38):5849-5862.
Manoj Yadav, Krishnadas Devdas, Jose Mathew, Neeraj Kv, Aniruddha Pratap Singh. Correlation between spleen size, platelet count and MELD score in cirrhosis. Journal of Clinical and Experimental Hepatology. 2018;8:S61.
Trimukhe R, Rai R, Wankhade NR. Etiological and clinical spectrum of liver cirrhosis In Eastern Madhya Pradesh, India. Journal of Clinical and Experimental Hepatology. 2011;1(1):18.
Vimal M, Parveen S. Clinico pathological profile of spectrum of thrombocytopenic cases – a cross sectional study. Trop J Path Micro. 2016;2(3):146-151.
Hugenholtz G, Porte R, Lisman T. The platelet and platelet function testing in liver disease. Clinics in Liver Disease. 2009;13(1):11-20.
Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553-8.
DOI: 10.1002/hep.20569 PMID: 15726661.
Giannini, Edoardo G Savarino, Vincenzo. Thrombocytopenia in liver disease, Current Opinion in Hematology. 2008;15(5):473-480.
Tripodi A. Hemostasis in acute and chronic liver disease. semiars in liver disease. 2017;37:28-32.
Peck-Radosavljevic M. Review article: Coagulation disorders in chronic liver disease. Alimentary Pharmacology & Therapeutics. 2007;26:21-28,21.
Shah A, Amarapurkar D, Dharod M, et al. Coagulopathy in cirrhosis: A prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics. Indian J Gastroenterol. 2015;34:359–364.
Segal JB, Dzik WH. Transfusion medicine/hemostasis clinical trials network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005 ;45(9):1413-25.
DOI:10.1111/j.1537-2995.2005.00546.x PMID: 16131373.
Premkumar M, Sarin SK. Current concepts in coagulation profile in cirrhosis and acute-on-chronic liver failure. Clin Liver Dis (Hoboken). 2020;16(4):158-167.
DOI: 10.1002/cld.976 PMID: 33163169; PMCID: PMC7609701.
Abstract View: 37 times
PDF Download: 9 times